Cutting Edge iPhone(TM)/iPod(R) Touch Apps Improve Quality of Life for Those With Celiac/Coeliac & Food... (/iand the Let's Eat Out!(TM) series en...)

Cutting Edge iPhone(TM)/iPod(R) Touch Apps Improve Quality of Life for Those With Celiac/Coeliac & Food Allergies

Date:7/31/2009

/i>and the Let's Eat Out!(TM) series encompass succinct content that has undergone rigorous focus group testing and quality assurance reviews with hundreds of individuals and chefs worldwide.

Based on over 6 years of extensive research, this series is endorsed by special diet associations and recognized by 200-plus media outlets. The enhanced book, Let's Eat Out with Celiac/Coeliac & Food Allergies! - published in June 2009, and the associated series are available from distributors, wholesalers, online and local bookstores in over 25 countries.

iEatOut(TM) is immediately available through Apple's iTunes Apps Stores with iEatOut LITE(TM) pending the Apple review process. For educational resources, visit www.AllergyFreePassport.com, www.GlutenFreePassport.com & www.GlutenFreeOnTheGo.com.

SOURCE AllergyFree Passport; GlutenFree Passport
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2
Related medicine news :

1. New STAR Cranial Center of Excellence Offers Cutting-Edge Treatment to Central Florida Infants
2. Los Angeles Surgeon Dr. Rezaian - Pioneers Cutting Edge Laser Back Surgery (laserbacksurgery.com)
3. Deerfield Spa, The Poconos Most Affordable Destination Spa, Schedules Ribbon-Cutting Event for Grand Opening of New Day Spa
4. Wisconsin Tobacco Tax Increase Is Positive Step for Health, but Budget Disappoints by Cutting Funding for Tobacco Prevention Programs
5. Top Dentist Issues Opinion on Health Benefits of Cutting-Edge Orthodontics
6. Surging Internet Use Cutting Into Family Time
7. Power Plate(R) Opens Cutting-Edge Studio in L.A.
8. Twelve Year-Old Girl With Facial Paralysis Is Smiling Again After Cutting-Edge Facial Plastic Surgery
9. Global Creative, Media and Technology Agency LBi Launches Cutting Edge Social Movement for the British Red Cross in Support of Refugee Week
10. AGA Institute presents cutting-edge research during DDW
11. Hispanics Placing Their Oral Health at Risk by Cutting Back on Routine Dental Care

Post Your Comments:

(Date:12/4/2009)...la., Dec. 4 NeoGenomic...ay that Steven C. Jones has been appointed Executi...oza has joined the company as Chief Financial Offi... all internal financial affairs of the Company. I... strategic initiatives on behalf of NeoGenomics as...

(Date:12/4/2009)...Mo., Dec. 4 Farmers Insurance Miss... Fire Marshal Randy Cole, and Brad Ballard, the CE...sponsored by Farmers called FireFacts , will ...ri Capitol December 9. ,, (Logo: http://www... "The call for fire safety comes following a tragi...

(Date:12/4/2009)...indings by UT Southwestern researchers suggest tha...s might also help slow the destruction of insulin-...h insulin-dependent (type 1) diabetes. , In typ... cells in the pancreas called beta cells, which pr...ess. , Researchers at UT Southwestern and 14 oth...

(Date:12/4/2009)...conveys true personality, study finds , ,...file on an online social network, such as Facebook...oes, reports a new study, which finds that people ...ized identities. , "I was surprised by the fin...eople are using their profiles to promote an enhan...

(Date:12/4/2009)...S, LLC, a leader in Pharmacy Inventory Management ...USA IDN Health Systems and hospitals valued at $22...mber to grow to over $30 million by the end of 200...December 4, 2009 -- PHACTS, LLC, a leader in Pharm... agreements in 2009 with USA IDN Health Systems an...

Breaking Medicine News(10 mins):Health News:NeoGenomics Announces Executive Appointments 2 Health News:Missouri Safety Day at the Capitol 2 Health News:FDA-approved drug may slow beta cell destruction in type 1 diabetes patients 2 Health News:Online Identities Likely to Match Reality 2 Health News:PHACTS Receives $22.4 Million in New Business Commitments 2

[0] NeoGenomics Announces Executive Appointments [0] Missouri Safety Day at the Capitol [0] FDA-approved drug may slow beta cell destruction in type 1 diabetes patients [0] Online Identities Likely to Match Reality [0] PHACTS Receives $22.4 Million in New Business Commitments

...oimmune disease is a condition in which the immune...gressively as it would attack a foreign pathogen. ... autoimmune disease, and is one of the most common...ttack the central nervous system. It has long been...

...lty from the University of Michigan , University... key collaborators in study , , DETROIT, April ...ecently discovered a chemical that plays a major r...rofessor of psychiatry in the School of Medicine a...

...-Week Data Supports Long-term Use of Vectical(TM) ... Patients - , , FORT WORTH, Texas, April 30 Gald...om a newly published clinical trial in this month,...o-moderate chronic plaque psoriasis. Of those pati...

...ches Women of Hope is Beautiful Campaign to Inspir...confidence, control, community, caring -- ask any...ly find meaning in these words. They are also inte...ent. The program, which is celebrating its 20th an...

...st radiosurgery solutions from Elekta discussed ...t the 2009 American Association of Neurological Su...iego Convention Center, Elekta customers and perso...nd oncologists today. , , Local Control of Brain...

...INTON, Mass., April 30 Alseres Pharmaceuticals, I... that on April 24, 2009 it entered into an Amendme...Therapeutic, Inc. (BioAxone), pursuant to which th...amended. The Amendment replaces all of the pre-co...

Other Medicine News:Health News:Gray matter under attack in multiple sclerosis 2 Health News:Gray matter under attack in multiple sclerosis 3 Health News:Wayne State University and Children's Hospital of Michigan Research Team Discover Chemical That Plays a Major Role in Pediatric Obsessive-Compulsive Disorder 2 Health News:Wayne State University and Children's Hospital of Michigan Research Team Discover Chemical That Plays a Major Role in Pediatric Obsessive-Compulsive Disorder 3 Health News:Wayne State University and Children's Hospital of Michigan Research Team Discover Chemical That Plays a Major Role in Pediatric Obsessive-Compulsive Disorder 4 Health News:Study Results Published in CUTIS Demonstrate Long-Term Safety and Efficacy of Vectical(TM) (calcitriol) Ointment 3 mcg/g in the Management of Mild-to-Moderate Plaque Psoriasis 2 Health News:Study Results Published in CUTIS Demonstrate Long-Term Safety and Efficacy of Vectical(TM) (calcitriol) Ointment 3 mcg/g in the Management of Mild-to-Moderate Plaque Psoriasis 3 Health News:Study Results Published in CUTIS Demonstrate Long-Term Safety and Efficacy of Vectical(TM) (calcitriol) Ointment 3 mcg/g in the Management of Mild-to-Moderate Plaque Psoriasis 4 Health News:Photos: Look Good. . .Feel Better Celebrates 20 Years of Helping Women Cope With Cancer 2 Health News:Photos: Look Good. . .Feel Better Celebrates 20 Years of Helping Women Cope With Cancer 3 Health News:Photos: Look Good. . .Feel Better Celebrates 20 Years of Helping Women Cope With Cancer 4 Health News:Elekta Radiosurgery Solutions are Creating New Possibilities for the Most Challenging Cases of the Head And Body 2 Health News:Elekta Radiosurgery Solutions are Creating New Possibilities for the Most Challenging Cases of the Head And Body 3 Health News:Alseres and BioAxone Amend License Agreement for Cethrin(R) and Rho Inhibitor Technology 2 Health News:Alseres and BioAxone Amend License Agreement for Cethrin(R) and Rho Inhibitor Technology 3 Health News:Alseres and BioAxone Amend License Agreement for Cethrin(R) and Rho Inhibitor Technology 4

Gray matter under attack in multiple sclerosis Wayne State University and Children's Hospital of Michigan Research Team Discover Chemical That Plays a Major Role in Pediatric Obsessive-Compulsive Disorder Study Results Published in CUTIS Demonstrate Long-Term Safety and Efficacy of Vectical(TM) (calcitriol) Ointment 3 mcg/g in the Management of Mild-to-Moderate Plaque Psoriasis Photos: Look Good. . .Feel Better Celebrates 20 Years of Helping Women Cope With Cancer Elekta Radiosurgery Solutions are Creating New Possibilities for the Most Challenging Cases of the Head And Body Alseres and BioAxone Amend License Agreement for Cethrin(R) and Rho Inhibitor Technology

(Date:12/3/2009)...Newswire-FirstCall/ -- Ted Karkus, Chairman and CE...w.quigleyco.com announced today that the Company ...to develop prescription pharmaceutical and OTC pro...erests to focus primarily on the OTC/Personal Care...d to its Cold-EEZE® and Kids-EEZE® brand...

(Date:12/3/2009)... Wound Management Tec...dly growing provider of specialty medical products...ustry Representative Association (HIRA) to serve a...representative to market the company,s core Celler...will market and sell Wound Management Technologies...

(Date:12/3/2009)...e/ -- Apnex Medical, Inc., a private medical devic...d round of private equity financing totaling $14 m...cal study and develop a second generation of its p...t obstructive sleep apnea (OSA). ,, Participant...Enterprise Associates (NEA), Polaris Venture Partn...

Breaking Medicine Technology:Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2 Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3 Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 2 Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 3 Apnex Medical, Inc. Raises Additional $14 Million 2 Apnex Medical, Inc. Raises Additional $14 Million 3 National Foundation for Infectious Diseases 28NFID 29 Survey 3A Parents More Flu Aware and More Likely to Get Kids Vaccinated 5552 1 National Foundation for Infectious Diseases 28NFID 29 Survey 3A Parents More Flu Aware and More Likely to Get Kids Vaccinated 5552 2 National Foundation for Infectious Diseases 28NFID 29 Survey 3A Parents More Flu Aware and More Likely to Get Kids Vaccinated 5552 3 National Foundation for Infectious Diseases 28NFID 29 Survey 3A Parents More Flu Aware and More Likely to Get Kids Vaccinated 5552 4 PhRMA Statement Supporting Fair Incentives for Biologics Innovation 5550 1 PhRMA Statement Supporting Fair Incentives for Biologics Innovation 5550 2 PhRMA Statement Supporting Fair Incentives for Biologics Innovation 5550 3 PhRMA Statement Supporting Fair Incentives for Biologics Innovation 5550 4 PhRMA Statement Supporting Fair Incentives for Biologics Innovation 5550 5 Genedata and the Institute of Experimental Medicine Academy of Sciences of the Czech Republic Collaborate on Asthma Bronchiale Project 14522 1 Genedata and the Institute of Experimental Medicine Academy of Sciences of the Czech Republic Collaborate on Asthma Bronchiale Project 14522 2 Genedata and the Institute of Experimental Medicine Academy of Sciences of the Czech Republic Collaborate on Asthma Bronchiale Project 14522 3 Genedata and the Institute of Experimental Medicine Academy of Sciences of the Czech Republic Collaborate on Asthma Bronchiale Project 14522 4

[0] Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution [0] Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up [0] Apnex Medical, Inc. Raises Additional $14 Million

... Extension of Phase II Study Demonstrates Signific...ne, LEXINGTON, Mass., June 12, 2007 /PRNewswire-Fi...nounced that results from the,Company,s Phase II E...ntal stuttering will be presented today at the 47t...on Unit (NCDEU), sponsored,by National Institute f...

... activity reported against CTCL, PTCL and Ovarian ...ire-FirstCall/ -- CuraGen,Corporation , a clinical...gy, presented today an update on the clinical deve...ase (HDAC) inhibitor, and,reported updated results...t cutaneous T-cell lymphoma (CTCL), peripheral T-c...

Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting CuraGen Presents Update on Clinical Development Program for,Belinostat

... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...

Medicine Products:

Eastern Equine Encephalitis Antibody, IgG by IFA, CSF E2A-PBX1, t(1;19) Translocation by RT-PCR E. coli O157:H7 Culture Dyphylline Quantitative, Urine

Cutting Edge iPhone(TM)/iPod(R) Touch Apps Improve Quality of Life for Those With Celiac/Coeliac & Food...(/iand the Let's Eat Out!(TM) series en...),Health